EIF4H and cancer: Indeed, eIF4H is detected in 93% of cancers (http://www.proteinatlas.org/ENSG00000106682/cancer), suggesting that eIF4H-mediated reprogramming of gene expression might be a general mechanism in tumoral development and a possible new therapeutic target.